Atlas Trials

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Clinical trial NCT00264433 · COMPLETED

Trial details

NCT number
NCT00264433
Sponsor
Adherex Technologies, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neoplasms

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.